• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Catalog Number BXA077901J
Device Problem Collapse (1099)
Patient Problem Occlusion (1984)
Event Date 05/26/2020
Event Type  Injury  
Manufacturer Narrative
The devices remain implanted in the patient, therefore they are not available for direct product analysis.Reference medwatch # 2017233-2020-00435 for other device.
 
Event Description
Following was reported to gore.On (b)(6) 2020, a patient underwent endovascular treatment of occlusion of the aorta and bilateral iliac arteries using gore® viabahn® vbx balloon expandable endoprosthesis(vbx).It was reported that the iliac arteries were highly calcified, and that the two vbx were placed by kissing stent technique.It was not reported which vbx were placed at which side.The procedure was completed without any issues.In mid (b)(6) 2020, the patient complained pain on the left leg, and she reported that the pain had recurred approximately two weeks after the initial procedure.An examination imaging revealed the vbx at the left common iliac artery was compressed and almost occluded.On (b)(6) 2020, a reintervention was performed.The vbx was relined using two additional stent grafts.The patient tolerated the procedure.The physician reported that the vbx might have been compressed by spine since the patient has a strong tendency to bend forward when standing position.
 
Manufacturer Narrative
Corrected data: h6.Results code 1.H6.Conclusions code 1.Additional manufacturer narrative: review of the manufacturing records verified that the lot met release requirements.The device was not returned.Consequently, a direct product analysis was not possible.Additional information about this event could not be obtained.As a result, no further investigation is possible.All information has been placed on file for use in tracking and trending.
 
Manufacturer Narrative
Additional manufacturer narrative: gore does not know which bxa085901j (lot #21632338 or lot #21632340) was implanted in the left iliac artery.Therefore, two medwatch reports have been submitted - reference medwatch #2017233-2020-00435 for the first device report.
 
Manufacturer Narrative
Additional manufacturing narrative: c1.Name (#1) - cbas® heparin surface; manufacturer/compounder: w.L.Gore & associates, inc.Lot #21632340.Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Manufacturer Narrative
Corrected data: conclusions code 1.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key10156034
MDR Text Key195236956
Report Number2017233-2020-00436
Device Sequence Number1
Product Code PRL
Combination Product (y/n)N
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 08/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/04/2022
Device Catalogue NumberBXA077901J
Device Lot Number21632340
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received06/15/2020
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Not provided
Not provided
Supplement Dates FDA Received06/30/2020
07/27/2020
07/30/2020
08/20/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-